ClinicalTrials.Veeva

Menu

Impact and Influence of the Use of Hypnosis Adapted to People With Severe Stage Neurocognitive Disorder (HAPNeSS) on the Professional Practices of EHPAD (Establishment for Dependent Elderly People) Caregivers With Elderly Residents (HAPNeSS-E)

U

University Hospital of Bordeaux

Status

Not yet enrolling

Conditions

Alzheimer Disease
Behavior Disorders

Treatments

Other: professional caregiver

Study type

Observational

Funder types

Other

Identifiers

NCT06535763
CHUBX 2023/87

Details and patient eligibility

About

The aim of this study is to propose a non-anxiety-inducing method of managing behavioral disorders for patients and healthcare professionals. The main objective of this study is to evaluate the implementation, use and effects of HAPNeSS (Hypnosis Adapted to People with Severe Neurocognitive Disorders) training on the management of residents aged over 75 with moderately severe to severe Alzheimer's disease or a related disorder, who may present behavioral disorders, with caregivers working in EHPAD.

Full description

The HAPNeSS method would offer caregivers the opportunity to find solutions to difficulties encountered (behavioral disorders, difficult care, etc.), to move away from pure technicality to reinvest in the relationship with the patient, and to find soothing, respectful and benevolent channels of communication. The aim of this study is to evaluate the effects of HAPNeSS (Hypnosis Adapted to People with Severe Neurocognitive Disorders) training on the care of residents over 75 with moderately severe to severe Alzheimer's disease or related disorders, who may present behavioral problems.

But also to measure, within each establishment, the effects of the HAPNeSS method, on the professional practices of caregivers (actions implemented, execution of missions, relationship with residents...) and to gather their feelings. These objectives therefore aim to collect and evaluate the effects of this method on the relationship between patients and caregivers, as well as on the latter's QWL. To achieve this, the research team organized 4 visits to the EHPADs participating in the study, spread over 6 months. Training takes place over 3 and then 2 days. Before and after the training, a visit at the beginning and end of the study will enable the scales to be administered and the interviews to be conducted. The data collected will be the subject of a mixed statistical analysis. Throughout the study, the research team will monitor the learning and development of each care professional.

Enrollment

36 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

EHPAD staff meeting the following criteria will be included in the study:

  • Nurses, care assistants, gerontological care assistants, psychologists, coordinating physicians, psychomotor therapists, occupational therapists;
  • More than one year's experience in the structure.

The study will examine the individual perceptions of EHPAD professionals of patients meeting the following criteria:

  • Be a resident of an EHPAD ;
  • suffering from a moderately severe or severe major neurocognitive disorder;
  • over 75 years of age.

Exclusion criteria

EHPAD professionals will not be included:

  • Not fluent in French,
  • Not wishing to be trained in hypnosis.

The individual perception of EHPAD professionals of patients meeting these criteria will not be questioned in the study:

  • Minor neurocognitive impairment, major neurocognitive impairment at a mild or moderate stage, or no cognitive impairment;
  • under 75 years of age.

Trial design

36 participants in 1 patient group

professional caregiver
Description:
nurse, care assistant, gerontological care assistant, psychologist, coordinating doctor, psychomotrician, occupational therapist in one of the 3 EHPADs in the study
Treatment:
Other: professional caregiver

Trial contacts and locations

1

Loading...

Central trial contact

Emma SALANNE; Marie FLOCCIA, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems